When comparing lung cancer patients to healthy individuals, the levels of exosomal EGFR were significant higher in five of nine lung cancer patients, while the levels of soluble EGFR in plasma were not significantly different in seven of nine lung cancer patients. This evidence concerns the gene EGFR and lung carcinoma.